||Growth Inhibition of 'Cryptococcus neoformans' by Human Alveolar Macrophages (Journal Version).
Weinberg, P. B. ;
Becker, S. ;
Granger, D. L. ;
Koren, H. S. ;
||Health Effects Research Lab., Research Triangle Park, NC. ;North Carolina Univ. at Chapel Hill. ;Environmental Monitoring and Services, Inc., Chapel Hill, NC.
Crytacoccus neoformans ;
Immunologic cytotoxicity ;
Blood serum ;
Pulmonary alveoli ;
Cultured cells ;
Immune system ;
||Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy.
||Macrophage cytotoxicity for Cryptococcus neoformans was investigated by culturing human alveolar macrophage (AM) with a thin-capsuled clone of C. neoformans. Under appropriate conditions, fungal replication was inhibited in the presence of human AM. The effect persisted over the 48-h time course that was evaluated. Human AM did not require endotoxin, fetal calf serum, or specific rabbit anticryptococcal antibody for fungistasis. Under these conditions, microscopic evaluation of a cytocentrifuge preparation of AM-yeast cocultures, stained by a modified Giemsa technique, revealed all the fungi to be extracellular. In the presence of 10 percent fresh human serum, AM phagocytized C. neoformans and exhibited fungicidal activity. Tumor necrosis factor did not affect the replication rate of the yeast. These findings suggest that there may be at least 2 mechanisms by which human AM protect against C. neoformans. One is serum-independent and extracellular and results in fungistasis, and the other is dependent on a serum factor and leads to intracellular inhibition of growth and possibly killing of the organism.
||Pub. in American Review of Respiratory Diseases, v136 p1242-1247 1987. Prepared in cooperation with North Carolina Univ. at Chapel Hill, and Environmental Monitoring and Services, Inc., Chapel Hill, NC.
|NTIS Title Notes
||Reprint: Growth Inhibition of 'Cryptococcus neoformans' by Human Alveolar Macrophages (Journal Version).
||Not available NTIS